Mensifem

Cimicifuga racemosa (black cohosh) dry extract, the active ingredient in Mensifem, is a herbal botanical presented as a standardized dry extract for oral administration. It is used to help manage menopausal symptoms, including hot flashes, night sweats, and mood changes, in adult women experiencing the physiological transition of menopause.

GNH USA supplies Mensifem as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality and regulatory conformity across markets.

Mensifem, a black cohosh dry extract, is employed within the therapeutic area of menopausal symptom relief. - Hot flashes: reduction in frequency and intensity of vasomotor episodes. - Night sweats: decreased nocturnal sweating and improved sleep quality. - Mood swings: stabilization of emotional fluctuations associated with menopause. - Sleep disturbances: promotion of more restful sleep patterns.

Mensifem is generally well tolerated, but adverse reactions have been reported.

Common Side Effects: - Gastrointestinal upset: mild nausea or stomach discomfort. - Headache: transient dull or throbbing pain. - Dizziness: occasional light‑headed sensation. - Skin rash: mild erythema or itching. - Fatigue: temporary feeling of tiredness.

Serious or Rare Side Effects: - Severe allergic reaction: anaphylaxis with swelling, breathing difficulty. - Liver injury: elevated liver enzymes or jaundice. - Stevens‑Johnson syndrome: severe skin blistering and mucosal involvement. - Hemorrhagic events: unexpected bleeding. - Thromboembolic events: rare clot formation.

Before using Mensifem, consider the following safety measures. - Medical history review: assess for liver disease or known hypersensitivity. - Pregnancy status: avoid use during pregnancy due to unknown safety. - Breastfeeding: discontinue if nursing, as safety has not been established. - Concomitant hormone therapy: consult a healthcare professional before combining. - Store at ambient temperature: keep in the original pack, protect from moisture and light.

Mensifem may interact with certain medicines; monitoring is advised.

Major Interactions (Avoid): - Combined estrogen therapy: potential additive hormonal effects. - Anticoagulants (e.g., warfarin): increased risk of bleeding.

Moderate Interactions (Monitor Closely): - Other phytoestrogen‑containing supplements: possible synergistic activity. - CYP450‑metabolized drugs: may alter plasma concentrations. - Selective serotonin reuptake inhibitors (SSRIs): could affect vasomotor symptom control.